Gapping up
In reaction to strong earnings/guidance: MELI +14.7%, SHOR +14.5%, ANET +12.2%, AGO +9.2%, BNFT +6.8%, GST +6.6%, MDVN +6.3%, AIRM +5.6%, AL +5.6%, GHDX +5.4%, NOG +4.8%, MHR +4.8%, GPS +4.7%, UBNT +4.6%, NVDA +4.5%, BAGR +4.4%, ELX +4.1%, UEIC +3.8%, AMRN +3.6%, DAR +3.5%, SPPI +2.9%, SCTY +2.8%, VVUS +2.6%, TUMI +2.4%, ZIOP +2.3%, CLNE +1.7%, PGNX +1.7%, CBS +1.4%, MNST +1.4%, YOKU +1.4%, TOUR +1.1%, WIFI +1%, BIOL +0.9%, .
M&A news: TI +4.1% (in discussions with Vivendi (VIVHY)'s GVT regarding merger, according to reports).
Select financial related names showing strength: RBS +3.2%, SAN +2%, UBS +1.7%, DB +1.5%, CS +1.1%, BCS +1%.
Select metals/mining stocks trading higher: SSRI +1.3%, VALE +1.2%, AUY +0.8%, IAG +0.8%, GG +0.6%, GDX +0.4%.
Other news: TKMR +14.9% (FDA Modifies co's TKM-Ebola Clinical Hold to Partial Hold), LULU +5% (confirms lululemon founder Chip Wilson and Advent International announce stock sale and support agreements; will sell ~13.85% of the co's outstanding shares, for ~$845 mln), HZNP +2.7% (Visium Asset Management discloses 5.5% passive stake in 13G filing), FRGI +2.6% (positive mention on Mad Money), MCRL +2.4% (Starboard disclosed 12.0% active stake in 13D filing), JCP +2.2% (positive Mad Money mention), LJPC +1.9% (Tang Capital disclosed 11.4% active stake in 13D filing), PLUG +1.4% (still checking).
Analyst comments: BCRX +4.6% (initiated with a Overweight at JP Morgan), NMBL +1.5% (initiated with a Outperform at Wells Fargo), MNST +1.4% (upgraded to Neutral from Sell at Longbow), ABX +1.3% (added to Conviction Buy list at Goldman), ATVI +0.7% (upgraded to Buy from Neutral at Longbow), EAT +0.5% (upgraded to Outperform from Mkt Perform at Raymond James)